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There are many biologic  and biochemical similarities between spontaneous tumor 
cells and those induced in model systems by oncogenic viruses. However, in contrast 
to most naturally occurring tumor cells, cells transformed by known oncogenic viruses 
are generally highly antigenic and consequently are rejected by an immunologically 
competent host.  Strong virus-specified cellular transplantation antigens, induced by 
DNA  viruses such  as  polyoma,  SV40, and  adenovirus, have  been clearly demon- 
strated by in vivo and in vitro techniques (see references  1-5). In the case of RNA- 
containing tumor viruses, there have been a number of reports of virus-induced trans- 
plantation antigens in routine sarcoma virus (MSV)l-transformed cells (6-12). How- 
ever,  these  latter  studies have  been performed with  MSV-transformed cells  which 
chronically release both MSV and murine leukemia virus (MuLV). It has, therefore, 
been difficult to distinguish antigenic changes associated with virus replication from 
those due to virus-coded, nonvirion  transplantation  antigens. 
It has recently been shown that MSV can transform mouse cells in vitro in the ab- 
sence of added MuLV but requires MuLV for its replication (13,  14). It was,  thus, 
possible  to  isolate MSV-transformed cell  lines which lacked any evidence of virus 
production or antigens but from which the sarcoma genome could be rescued by in- 
fection with MuLV (13, 14). The fact that these lines were derived from a parent clone 
of contact-inhibited, nontumorlgenic, syngeneic mouse cells,  BALB/3T3 (15),  made 
it possible to  determine whether  MSV,  in the absence of virus production, induces 
detectable virus-specified transplantation antigens in transformed cells. 
Materials and Methods 
Mice.--O-8-wk old female BALB/c mice were obtained from the National Institutes of 
Health  (NIH) breeding colony, Bethesda, Md. 
Cells and Viruses.--Cells were grown in Dulbecco's modification of Eagle's medium supple- 
mented with  10% calf serum. From a clonal line of BALB/3T3,  clone A31  (15), a Kirsten 
(Ki)-MSV  transformed subclone, K-234, was isolated which produced no detectable  virus 
(16). Similar BALB/3T3 nonproducer transformants of the Moloney (M) strain of MSV have 
been previously described (13). A line of MSV- and MuLV- producing transformed cells was 
obtained by infecting K-234 cells with Rauscher (R)-MuLV. The K-234(R) subclone chroni- 
cally released around 2 )< 105 focus-forming units (FFU)/ml of MSV and 3 >(  106 infectious 
1  Abbreviations used in this paper: FA, fluorescent antibody; FFU, focus-forming units; 
Ki, Kirsten; M, Moloney; MSV, murine sarcoma virus; MuLV, murine leukemia virus; NRK, 
normal rat kidney; R, Rauscher. 
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units/ml  of  R-MuLV.  An  SV40-transformed BALB/3T3  subclone,  SV-T2,  has previously 
been described  (17).  Other cells included a  normal rat kidney  (NRK)  cell line  (18)  and a 
KiMSV-transformed  nonproducer  clone  of  NRK  cells,  K-NRK  (16).  R-MuLV,  twice- 
banded in sucrose and concentrated 1000-fold,  was obtained from  Electro-Nucleonics,  Inc. 
Bethesda, Md.  Other viruses used  included  KiMSV(KiMuLV)  and  KiMSV(R)  (16).  For 
some studies, viruses were inactivated by ultraviolet irradiation for 15 min as previously de- 
scribed (19). 
Immunizing Procedure.  Cells were trypsinized, washed twice by centrifugation, and re- 
suspended in serum-free medium at the appropriate concentration. Injections were made sub- 
cutaneously in the thigh in a volume of 0.2 ml. For some immunizations cell suspensions main- 
tained on ice were ultrasonically disrupted for 60 sec at 60 w with a 1/2 inch sonic probe (Sonifer 
Cell Disruptor Model W185D, Branson Sonic Power Co., Danbury, Conn.). 
Cytotoxicity.--A modification of  the method of HellstrCm  and  Sj/Jgren  (5)  was used for 
cytotoxicity studies. Target cells were trypsinized, washed three times,  and resuspended in 
medium at 104 cells/ml. 0.25 ml serum was mixed with an equal volume of cells and incubated 
at 37°C for 30 rain, followed by the addition of 0.25 ml of guinea pig complement and incuba- 
tion for a  further 60 rain. The cell suspensions were then diluted  1:10 in medium and dis- 
tributed to 50-ram Petri dishes  (Falcon Plastics, Div. B-D Laboratories, Inc.,  Los Angeles, 
Calif.) at 4 ml/dish. After incubation for 7 days at 37°C,  the Petri dishes were stained with 
hematoxylin and  the colonies were counted. 
Virus Neutralization.--Virus neutralization was performed by a  focus reduction method. 
Antisera were heat inactivated at 56°C for 30 min. Around 50 FFU of MSV were incubated 
with the appropriate serum dilution for 30 rain at 37°C and then assayed for focus formation 
on diethylaminoethyl (DEAE)-dextran-pretreated NRK cells as previously described (13). 
Fluorescent Antibody Detection of Cell Surface Antigens.--An indirect fuorescent antibody 
(FA)  technique was used to detect cell surface antigens. Sera from hamsters, bearing an in 
vivo-induced MSV-nonproducer tumor, HT-1  (20),  were a  gift of G.  Kelloff of  NIH.  Sera 
from rats carrying a  transplantable MSV-producing tumor were obtained from R. Wilsnak, 
Huntington Research Laboratories, Baltimore, Md.  Fluorescein-conjugated goat antisera to 
rat, hamster, and mouse globulins were obtained from the Resources and Logistics Segment of 
the National Cancer Institute. Cells growing on cover slips were washed twice in phosphate- 
buffered saline and incubated at 37°C for 30 rain with antiserum, washed again, and incubated 
30 rain with the appropriate fluorescein-conjugated antiglobulin at a final dilution of 1:6 with 
lissamine rhodamine (1:60 dilution) as counterstain. Cell surface antigens were scored with a 
Leitz fluorescent microscope  0<  400). 
RESULTS 
Comparison of the Tumorigenicity of MSV-Transformed Nonproducer and Pro- 
ducer  Cell  Lines.--The  present  study  was  undertaken  to  determine  whether 
the immunogenicity  of murine sarcoma virus-transformed  cells is due to  anti- 
gens  associated  with  virus  production,  or  whether  MSV-transformed  cells 
possess  new  virus-specified  nonvirion  transplantation  antigens.  The  tumor- 
forming  ability  of  an  MSV-transformed  nonproducer  clonal  line,  K-234, 
was  compared  with  that  of  the  identical  cell  line  preinfected  with  R-MuLV 
and producing  both  sarcoma  and  leukemia  viruses.  As  can be seen in Fig.  1, 
at  each  cell  dose  tested  the incidence  of  tumor  formation  in mice  inoculated 
with  K-234  was  much  higher  than  with  K-234(R).  Tumors  induced  by  K- 
234(R)  cells  grew  rapidly  for  the first  2  wk,  but  only very  slowly  thereafter; 
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tumors  induced  by  the  nonproducer  cell  line  grew  progressively  and  even- 
tually killed the host. This is reflected in the much higher death rate for mice 
injected  with  K-234  as  compared  to  K-234(R)  cells  (Fig.  2).  Clearly,  the 
presence  of  replicating  virus  in  K-234(R)  cells  was  associated  with  their 
having a markedly reduced malignant potential.  The most likely explanation 
was  that  the  virus-producing  cells were more  antigenic  than  the  MSV  non- 
producers. 
To test whether this was the case, the effect of irradiation of the host on the 
tumorigenicity of the  two  cell lines  was compared.  Mice which  received 250 
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FIG.  1.  Comparison  of  the  tumorigenicity  of  MSV-producer  nonproducer  BALB/3T3 
lines in syngeneic  BALB/c mice. Animals  were inoculated subcutaneously in the interscapular 
region with 2 X 104, 105, or 5 X 105 cells. O, K-234;/X, K-234(R). 
rads  whole  body irradiation  and  unirradiated  controls  were  inoculated  sub- 
cutaneously  with  either  MSV-nonproducer  or  virus-producing  transformed 
cells.  As shown in Table I, irradiation had little if anv effect on the death rate 
of  animals  receiving  MSV-nonproducer  cells.  However,  the  producer  cells 
grew  much  more efficiently in  immunologically suppressed  mice than  in  the 
nonirradiated  controls.  This  result  further  suggests  that  the  virus-producing 
MSV-transformed cells were much more immunogenic than  the nonproducer 
cells. 
Tumorigenicity  of MSV-Nonproducer  and  Producer  Cells in  Preimmunized 
BALB/c Mice.--In  order  to resolve whether  the nonproducer  cells possessed 
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immunity experiments were performed. BALB/c mice were immunized  sub- 
cutaneously with K-234,  K-234(R),  or  the parent  clone of BALB/3T3 with 
four successive weekly doses of 5  X  10  a cells/animal.  1 wk after the last im- 
munizing injection, the animals were challenged with either K-234 or K-234(R) 
cells. As shown in Table II, preimmunization with the producer cells markedly 
reduced the tumor incidence in mice subsequently challenged with the homol- 
ogous  cells.  Only  one  tumor  developed in  60  animals  preimmunized  with 
K-234(R) as compared to 26/50 in mice  pretreated with  control  BALB/3T3 
ceils. In contrast, there was no significant reduction in tumorigenicity of K-234 
cells in mice preimmunized with  K-234 as compared to those preimmunized 
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FIG.  2.  Comparison of  the  survival  of  mice inoculated  with  MSV-producer  and  non- 
producer cells. O,  K-234; ~,  K  234(R). 
with BALB/3T3. A  small reduction in  tumor-forming ability of both K-234 
and K-234 (R) was seen in mice preimmunized with BALB/3T3. This may be 
due  to  antigenic changes in  the BALB/3T3 ceils after prolonged passage  in 
culture (21). 
In  another  study,  animals  were  preimmunized  with  BALB/3T3,  K-234, 
or K-234(R)  at 5  X  104 cells/injection; here, cells were first sonicated  to  re- 
duce  tumor induction  during  immunization.  From  the  results  in  Table  III, 
it  is  clear  that  preimmunization  with  sonicated  K-234(R)  cells  effectively 
prevented  challenge  by  the  homologous  cells.  There were  no  tumors  in  60 
K-234(R)-preimmunized  animals  compared  to  27/53  in  BALB/3T3-pre- 
immunized  controls.  Again,  the  nonproducer  cells  were  no  more  effective 
than  BALB/3T3 itself in  protecting mice from challenge with  either K-234 
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Tumorigenicity  of Nonproducer  Cells  in  BALB/c  Mice  Preimmunized with 
Xenogeneic Nonproducer Cells.--Transplantation  immunity studies were  also 
performed  by preilnmunizing BALB/c mice with  a  KiMSV rat nonproducer 
cell  line,  K-NRK.  By use of  this xenogeneic cell  line, it  was possible to  ira- 
TABLE I 
Effect ~  Hostlrradiation on the Tumor@enicity ~  MSV-Producerand Nonproducer Cells 
Tumor challenge*  % Deaths due to progressive tumor growth:~ 
Clone  Cell dose  Control  Preirradiated 
K-234  103  0  0 
104  0  5 
10  s  20  25 
K-234(R)  10  ~  0  52 
104  0  84 
105  4  96 
* 25 mice in each group were challenged at the indicated cell doses with the appropriate 
cells injected subcutaneously in the interscapular region. 
:~ Determined at 4 wk after inoculation. 
TABLE II 
Tumorigenicity of MSV-Produ6er and Nonproducer Cells in Mice Preimmunized with Viable 
Cells* 
Tumor challenge:~  Pretreatment 
Clone  Cell dose  Untreated  BALB/3T3  K 234(R)  K-234 
K-234 
K-234(R) 
2  X  104  5/18  2/19  N.D.§  1/15 
1 X  105  11/19  5/18  N.D.  2/13 
5  X  1@  18/18  11/17  N.D.  7/13 
2  X  104  17/17  12/17  0,/20  N.D. 
1 X  105  12/17  7/16  0/20  N.D. 
5  X  10  ~  12/17  7/17  1/20  N.D. 
* Mice were preimmunized weekly for 3 consecutive wk with 2.5  X  103 viable cells in- 
jected subcutaneously in the thigh region. 
:~ Mice were challenged at the indicated cell doses subcutaneously in the interscapular re- 
gion 1 wk after the final preimmunizing injection. Results are expressed as the fraction of 
tumor-bearing mice at 5 wk. 
§ Not done. 
munize with very high cell doses without producing tumors during immuniza- 
tion.  If  virus-specific  transplantation antigens  were  present  on  the  MSV- 
nonproducer rat  cells,  these  might  be  capable  of  immunizing mice  against 
subsequent challenge by MSV-nonproducer mouse cells.  It can be seen from 
the results in Table IV that K-NRK ceils were no more effective than NRK 
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along  with  the  results  in  Tables  II  and  III  demonstrate  that  the  MSV-non- 
producer  cells  clearly  lacked  evidence  of  virus-specific  transplantation  anti- 
gens  detectable  by  transplantation  immunity  studies. 
Tumorigenicity  of  MSV-Transformed  Producer  and  Xonproducer  Cells  in 
Rauscher  Virus  Preimmunized  Mice.--From  the  above  studies,  it  seemed 
TABLE  III 
Tumorigenicity o  j" MS V-Producer and Nonproducer Cells in Mice Preimmunized with Sonicated 
Cells or UV-Inactivated R-MuLV* 
Tumor challenge  Pretreatment 
Clone  Cell dose  Untreated  BALB/3T3  K-234(R)  K  234  R; 
K-234  2  X  104  3/6  0/5  N.D.§  0/3  N.D. 
1  X  105  3/6  2/5  N.D.  2/5  N.D. 
5  X  105  6/6  2/5  N.D.  3/5  10/10 
K-234(R)  2  ;K  104  17/1711  8/17  021  5/9  N.D. 
1  ;K  105  12/17[[  9,/18  0/20  3/7  N.D. 
5  X  10 ~  12/171!  10/18  0/19  2/5  1/10 
* Preimmunizations and challenge injections were carried out as described in the legend to 
Table II with the exception that the celt dose for preimmunizations was increased to 5 X  104 
cells/animal and the cells were sonicated for 60 sec before injection. Results are expressed  as 
the fraction of mice bearing tumors at 5 wk. 
Preimmunizations  were carried  out  as  above,  but  with  twice-banded,  UV-inactivated 
P,  auscher leukemia virus at a dose of approximately 108-109 physical particles/injection. 
§ Not done. 
LI Same data as in Table II. 
TABLE  IV 
Tumorigenicity of MSV-Producer  and  Nonprodueer Cells in  Mice Preimmunized with 
Xenogeneic MSV-Nonproducer Cells* 
Tumor challenge;  Pretreatment 
Clone  Cell dose  Untreated  NRK  K-NRK 
K-234  1 X  10  a  9//10  12/20  14/20 
* Mice were preimmunized weekly for 3 consecutive wk with 5 X  105 viable cells  injected 
subcutaneously in the thigh region. 
:~ Tumor challenges were performed as described in Table II. Results are expressed as the 
fraction of mice bearing tumors at 5 wk. 
likely that  the transplantation  antigens  of K-234(R)  cells  were  primaril)  due 
to maturing virus at the cell surface.  To directly test this possibility, mice were 
imnmnized  weekly  for  3  consecutive  wk  with  UV-irradiated  R-MuLV  (ap- 
proximately  l0  s  109  particles  per  injection)  and  then  challenged  1  wk  later 
with  the  K-234  and  K-234(R)  lines  at  5  X  10 a  cells/animal.  As  shown  in 
Table  III,  R-MuLV  was  able  to prevent  subsequent  challenge  by  K-234(R) 
but  had  no  effect on  the  tumorigenicity  of K-234  cells.  These  results  demon- JOHN  R.  STEPHENSON  AND  STUART  A.  AARONSON  509 
strate  that  the  transplantation  antigens  detected  in  virus-producing  MSV- 
transformed  cells  are  to a  large extent  due  to viral  structural  proteins  at  the 
cell surface. 
Cytotoxicity and  Fluorescent Antibody  Studies.--It  was possible  that in vivo 
methods were not sufficiently sensitive  to detect weakly antigenic cell surface 
changes  in  the  MSV-nonproducer  cells.  For  this  reason,  a  series  of in  vitro 
cytotoxicity  and  fluorescent  antibody  studies  were  performed.  Sera  from 
BALB/c mice bearing  tumors  induced  by the  producer  cell  line,  K-234(R), 
and  from  untreated  mice  were  tested  for  cytotoxic  activity  against  K-234, 
K-234(R),  and  BALB/3T3.  As  shown  in  Table  V,  there  was  a  decrease  of 
more  than  50%  in  the  colony-forming  ability  of K-234(R)  cells  exposed  to 
serum  from  K-234-preimmunized  mice.  In  contrast,  there  was  only a  small 
decrease  in  the  colony-forming ability  of  either  K-234  or  BALB/3T3  cells. 
From  these  studies,  it  is  concluded  that  K-234(R)  tumor-bearing  mice  had 
TABLE V 
Cytotoxicily of Sera from Mice Immunized wBh MSV Producer Cells 
Colony  number* 
Target cell  % Reduction+  + 
Control  sera  Antisera 
BALB/3T3  31.6  4-  2.9  29.6  4-  2.6  8.2 
K-234  25.8  =t= 3.2  22.0  4-  2.1  14.7 
K-234(R)  14.2  4-  1.6  6.6  4-  0.7  53.5 
* Number of colonies per plate based on six individual plates per group  (mean 4-  1 sE). 
:~ Determined by subtracting  from the average number of colonies formed by the control 
serum-treated cells the number formed by the antiserum-treated  cells, and expressing this as 
a percentage of the number of colonies formed by the control cells. 
circulating  antibodies  which  were  cytotoxic to K-234(R)  cells  but  not  more 
toxic to K-234 than to BALB/3T3 target cells. 
The  MSV-producer,  nonproducer,  and  control  BALB/3T3  cells  were  ex- 
amined by a  fluorescent antibody method which detects  cell  surface antigens. 
With  sera  obtained  from  BALB/c  mice  preimmunized  with  each  cell  line, 
specific  staining  of the  cell  surface  was  observed  only when  sera  from mice 
preimmunized with K-234(R)  cells  were  tested  against the same cell line.  As 
shown in Table VI, the surface antibody titer was 1:50 before and  1:30 after 
adsorption with BALB/3T3 cells.  A  small but definite reaction was seen with 
antiserum  to  MSV-producer  cells  against  both  BALB/3T3  and  K-234  cells, 
but  this  was eliminated  by adsorption  of the  serum  with  control BALB/3T3 
cells.  The reactivity  of sera from mice preimmunized  with  MSV-nonproducer 
cells  was  not  specific  for  the  MSV-transformed  cells  and  was  eliminated  by 
adsorption  with  BALB/3T3. 
Sera  obtained  from  two  other  species  imnmnized  with  MSV  tumors  were 
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technique.  Sera  from  rats  bearing  a  transplantable  MSV-producing  tumor, 
M-MSV(R),  had  a  surface  antibody  titer  of  over  1:200  against  K-234(R) 
cells  (Table  VI).  In  striking  contrast,  this  serum  was  not  reactive  against 
either  K-234  or  BALB/3T3  cells.  Sera  from  hamsters  immunized  with  an 
MSV-nonproducer hamster  tumor,  HT-1  (20),  showed no reactivity with  any 
of the mouse cell lines.  Thus,  while in vitro cytotoxicity and fluoresence anti- 
body  tests  readily  detected  surface  antigens  on  virus-producing  MSV-trans- 
formed BALB/3T3  cells,  neither  method  allowed  detection  of  MSV-induced 
surface antigens on the MSV-nonproducer cells. 
Virus XeutraIization Studies.--It was of interest  to determine  whether virus 
neutralizing  antibodies  could  be  detected  in  sera  of  mice  immunized  with 
either  the  MSV-producer  or nonproducer  cell  lines.  Each  was  tested  against 
TABLE VI 
Fluorescent Antibody Detection of Sub:face Antigens qf MSV Producer and Nonproducer Cells 
Fluorescent antibody tiler* 
Species  Cells used for immunization  Cells used for  Target cells 
absorption; 
BALB/3T3  K-234  K-234(R) 
Mouse  K-234  2  2  2 
K-234  BALB/3T3  Neg  Neg  Neg 
K-234(R)  -  2  3  50 
K-234(R)  BALB/3T3  Neg  Neg  30 
BALB/3T3  -  2  2  2 
Rat  M-MSV(R)  < 2  < 2  200 
Hamster  HT-1  -  <2  <2  <2 
* The titer is the reciprocal of the highest serum dilution which gave a positive reaction. 
~c Sera were preabsorbed by incubation with an equal volume of packed cells for 30 rain at 
4°C. 
the  virus  stock  originally  used  to  transform  the  MSV-nonproducer  cells, 
KiMSV(KiMuLV),  and  against  the  virus  produced  by  K-234(R)  cells.  As 
is  shown  in  Table  VII,  the  sera  from K-234(R)-inoculated  mice  contained 
neutralizing  antibodies  to the R-MuLV pseudotype of KiMSV with  a  titer of 
1:20.  Neither  this  serum  nor  sera from mice immunized with  the  MSV-non- 
producer cells inhibited focus formation by KiMSV(KiMuLV). 
Comparison of the  Tumorigenicity of MSV-  and SV40--Transformed  Ceils.- 
Previous studies  have  demonstrated  that  the  malignant  potential  of in vitro 
cultivated inbred mouse cell lines is related  to their lack of contact inhibition 
of cell division. Thus, under experimental  conditions where the host's immune 
defenses were suppressed by total body irradiation,  SV40 transformed-BALB/ 
3T3  cells  which  grew to a  very high  saturation  density  in culture  were very 
tumorigenic  (17).  The  ability  of  this  previously  reported  SV40-transformed 
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mice was compared with the tumorigenicity of the MSV-transformed cells of 
the present study. As shown in Table VIII, SV-T2 was at least 3  log units less 
tumorigenic in unirradiated  animals than  the  MSV-nonproducer cells,  even 
though  the  SV40-transformed  cells  achieved  a  higher  saturation  density in 
culture.  The  tumorigenicity  of  K-234(R)  was  approximately  50-fold  less 
than that of K-234 but still far greater than that of SV-T2. These findings  indi- 
cate  that  the  transplantation  antigens  of  even  the  virus-producing MSV- 
TABLE  VII 
Neutralization of Focus Formation by KiMSV(KiMuLV)  and KiMSV(R)  with Sara from 
Immunized BA LB/c Mice 
Neutralizing titer* 
Virus  Sara from animals immunized with the following cells 
BALB/3T3  K-234  K-234(R) 
KiMSV(KiMuLV)  < 2  < 2  < 2 
KiMSV(R)  <2  <2  20 
* Approximately 50 FFU of each virus were incubated with an equal volume of the appro- 
priate  serum for 30 rain at 37°C and then assayed for focus formation on NRK cells. The 
end-point  titer was  the highest serum dilution giving more than 70~.  inhibition of focus 
formation. 
TABLE  VIII 
Comparison of the Tumorigenicity of MSV-Transformed and SV40-Transformed BALB/3T3 
Cells* 
Cell  number required for  Challenge cells  Saturation density in culture  50% tumor incidence 
cells~era2 
K-234  3.5  X  105  1  X  104 
K-234(R)  3.7  X  105  5  X  105 
SV-T2  >10  X  10 ~  >7  X  10  7 
* Tumor challenges were carried out as described in Table II. 
:~ The maximum cell number attained when 5 X  10  ~ cells/cm 2 were inoculated into 20- 
cm  2 Petri dishes under conditions where medium containing 10c~ calf serum was changed 
every 3 days. 
transformed  cells  are  far  less  immunogenic than  those  of  cells  transformed 
nonproductively  by SV40. 
DISCUSSION 
Mouse cells that  are infected by MSV in the absence of added MuLV be- 
come strikingly altered in their morphology in tissue culture and attain the 
ability to  form tumors in vivo. MSV-transformed clonal lines of  this nature 
have  so  far  been  found  to  lack  any  evidence of  virus  production or  viral- 
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ceils with MuLV results in rescue of the MSV genome. In the present study, 
we compared the antigenicity of virus-producing and MSV nonproducer trans- 
formed ceils in order  to determine whether virus-coded,  nonvirion transplan- 
tation  antigens could be detecled.  The system was very well suited  for these 
studies because: all celt lines were derived from a clonal line of nontumorigenic, 
syngeneic mouse  embryo cells;  the  MSV-  and  MuLV-producing  transformed 
line  was obtained by MuLV  infection  of the  nonproducer  clonal  line  so that 
otherwise they were identical;  and neither  the producer nor the nonproducer 
cell lines had been preselected by in vivo passage. 
In  the present  studies,  MSV-transformed virus-producing  cells had  clearly 
demonstrable  virus-specific transplantation  antigens.  The  number  of  deaths 
due  to  progressive  tumor  growth  when  raice  were  injected  with  K-234(R) 
cells was greatly increased when mice were irradiated before tumor challenge. 
Furthermore,  preimmunization  with  K-234(R)  cells  considerably  reduced 
the  fraction  of mice developing tumors  after  challenge  with  the homologous 
cell  line. In in vitro studies, surface antigens were detected  on K-234(R)  cells 
by  fluorescent  antibodv  and  cytotoxicity  tests.  Finally,  preimmunization  of 
syngeneic mice with  UV-inactivated,  purified  R-MuLV  effectively protected 
them  from subsequent  challenge  with  K-234(R).  It  is  concluded  from  these 
findings  that  the  immunogenicity of virus-producing  MSV-transformed  cells 
is  to  a  large  extent  attributable  to  surface  antigens  associated  with  virus 
production. 
In striking contrast, the MSV-transformed nonproducer cells were found by 
each of the above procedures to be no more immunogenic than control BALB/ 
3T3  cells.  One possible explanation for our results is that  MSV  does not in- 
duce  cell  surface  alterations.  However, it has been  demonstrated that  MSV- 
transformed cells have a markedly altered glucose transport  (22),  and recent 
studies  indicate  a  small  but  significant  increase  in  agglutinability  of  MSV- 
transformed compared to normal cells in response to plant lectins such as con- 
canavalin  A  (B.  Ozanne,  personal  communication).  These  findings  provide 
biochemical  evidence  that  surface  alterations may be present  in  MSV-trans- 
formed cells. 
If MSV does in fact induce cell  surface changes, these clearly were not de- 
tectable by the immunologic techniques used in the present report. To explain 
these  results,  host  factors  such  as  blocking  antibodies  which  have  been  de- 
scribed for RNA tumor virus  producing cells (23)  or antigenic modulation (24) 
could be invoked. However, the fact that sera from mice preimmunized with 
virus-infected,  transformed  cells  appeared  to  lack  both  cytotoxic  and  FA 
surface staining antibodies  against in vitro-cultured  nonproducer cells  argues 
against both of these possibilities.  Further  considerations are that cell surface 
alterations  induced  by  MSV  are  not  immunogenic  because  they  represent 
either:  (a)  modified  production  of  normal  cell  components:  (b)  virus-coded 
antigens which are poorly, if at all,  immunogenic because of either their strut- JOHN  R.  STEPtIENSON  AND  STUART  A.  AARONSON  513 
ture  or location;  (c)  derepression  of embryonic antigens;  or  (d)  virus-coded 
antigens to which the animal is tolerant. The last possibility is unlikely in view 
of inability  of sera from MSV-immunized  animals  of two  other species,  the 
rat and hamster, to detect antigens in MSV-nonproducer mouse cells. A further 
resolution  of  these  possibilities  should  increase  our  understanding  of  the 
mechanism of transformation by MSV. 
A  previous  study  (25),  in  which  MSV-transformed  nonproducer  hamster 
tumor cells  were found to be ineffective in protecting mice from subsequent 
challenge  with  virus-producing sarcoma  cells,  supports  the  present  findings 
that  MSV  nonproducer  cells  lack  detectable  surface  antigens.  In  contrast, 
there  have  been  two  reports  of  virus-specific  "transplantation  antigens" 
in MSV-transformed, supposedly virus-free cell  lines.  In one study, Ting  (9) 
demonstrated  transplantation  resistance  in  inbred  rats  to  a  "nonproducer" 
tumor  cell  line  designated  MSB-1.  However,  this  cell  line  was  later  shown 
to release both  a  focus-forming virus,  MSV(0)  (26),  and  a  rat-tropic  helper 
leukemia virus (27). In light of the present studies, it is likely that the  trans- 
plantation antigens associated with these cells were in large part due to  repli- 
cating  virus.  In  a  more  recent  report,  transplantation  resistance  against  a 
mouse tumor line, XM-1,  was reported in mice immunized either with XM-1 
cells or with MSV(MuLV) (11). However, these cells, too, were later found to 
produce C-type virus particles (Ting, personal communication). 
The  morphologic  and  growth  properties  of  MSV-producing  and  nonpro- 
ducer transformed mouse cells  are indistinguishable in tissue culture (13,  16). 
Yet, the present report shows that the tumor-forming ability of nonproducer 
cells is far greater in an immunologically competent host. The results demon- 
strate  that  MSV  nonproducer  cells  lack  detectable  virus-specified  surface 
antigens  and  that  the immunogenicity of virus-producing MSV-transformed 
cells is due to the presence of virion antigens at the cell surface. If RNA tumor 
viruses have an etiologic role in spontaneous tumors, it is  apparent from the 
present studies that the selective growth advantage of an in vivo transformed 
nonproducer cell  over its virus-producing counterpart might well account for 
the difficulty in detecting virus production in naturally occurring neoplasms. 
SUMMARY 
The  isolation  of  clonal  lines  of  murine  sarcoma  virus-transformed,  non- 
producer  BALB/3T3  cells  has  provided  a  model  system  for  determining 
whether RNA tumor virus-transformed cells possess virus-specific transplanta- 
tion antigens.  MSV nonproducer cells  (K-234)  were clonally derived from  an 
inbred  mouse  cell  line,  BALB/3T3. A  parallel virus-producing cell  line was 
obtained by infection of the MSV nonproducer cells with Rauscher leukemia 
virus. K-234 was much more tumorigenic than K-234(R). Preimmunization of 
syngeneic mice with  either K-234(R)  or with  UV-inactivated  Rauscher  leu- 
kemia virus induced  transplantation  resistance to subsequent  challenge with 514  ANTIGENIC  PROPERTIES  OF  MSV-TRANSFORMED  CELLS 
K-234(R),  but not with K-234. In contrast, mice preimmunized with nonpro- 
ducer cells were not made resistant to subsequent challenge with the homologous 
cells. Antisera prepared from mice immunized with K-234(R) were specifically 
cytotoxic and  positive by fluorescent antibody staining  for  K-234(R)  target 
cells,  but  not  to  either  BALB/3T3  or  K-234.  The  results  show  that  MSV 
nonproducer  cells lack detectable  transplantation  antigens  and  suggest  that 
the transplantation resistance to the producing cells is attributable to matur- 
ing virus at the cell surface. 
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